KYNAM GLOBAL HEALTHCARE MASTER FUND, LP sold 16.24M shares of 2SEVENTY BIO, INC. on the open market
Open‑market sale worth $80.05M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/13/2025ACC: 0000919574-25-001923
10% Owner
Since Aug 2023
-16.24M
Net shares
Net seller
$80.05M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
16.24M disposed
Non-Derivative Transactions3
Common Stock, par value $0.0001 per share
Indirect
Shares
−5.95M
Price / share
$4.93
Trade value
$29.35M
% of position
New position
3/11/2025
5.95M→0.00
Common Stock, par value $0.0001 per share
Direct
Shares
−5.14M
Price / share
$4.93
Trade value
$25.35M
% of position
New position
3/11/2025
5.14M→0.00
Common Stock, par value $0.0001 per share
Indirect
Shares
−5.14M
Price / share
$4.93
Trade value
$25.35M
% of position
New position
3/11/2025
5.14M→0.00
Total
Net shares
−16.24M
Net value
-$80.05M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 3/11/2025 | S · Sale | −5.95M | $4.93 | $29.35M | New position | 5.95M | 0.00 |
| Common Stock, par value $0.0001 per share Direct | 3/11/2025 | S · Sale | −5.14M | $4.93 | $25.35M | New position | 5.14M | 0.00 |
| Common Stock, par value $0.0001 per share Indirect | 3/11/2025 | S · Sale | −5.14M | $4.93 | $25.35M | New position | 5.14M | 0.00 |
| Total | −16.24M | -$80.05M | ||||||
Derivative Transactions0
No derivative transactions reported